dalteparin has been researched along with Erythema in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phillips, JK | 1 |
| Majumdar, G | 1 |
| Hunt, BJ | 1 |
| Savidge, GF | 1 |
1 other study available for dalteparin and Erythema
| Article | Year |
|---|---|
Heparin-induced skin reaction due to two different preparations of low molecular weight heparin (LMWH)
Topics: Adult; Dalteparin; Drug Eruptions; Enoxaparin; Erythema; Female; Femoral Vein; Humans; Iliac Vein; P | 1993 |